DCK and multiple sclerosis: -dCK inhibitors block the salvage of intact pyrimidine deoxyribonucleoside dC, dA and dG (10, 37)-dCK inhibition is effective for the treatment of multiple sclerosis in mouse models (184, 185)-TRE-515 is under clinical investigation for the treatment of solid tumors (NCT05055609) (119)